| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_364361dcadbe698011b0554cccff370b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65846 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6584
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2009-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b17c8153d4ead595e1e125efad829d73 |
| publicationDate |
2009-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009202540-A1 |
| titleOfInvention |
Substituted oxazaphosphorines |
| abstract |
The present invention relates to new oxazaphosphorine alkylating agents and/or immuno-suppressive agents, pharmaceutical compositions thereof, and methods of use thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019298710-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014004376-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10925869-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11491154-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012164578-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102516306-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11672795-B2 |
| priorityDate |
2008-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |